General Information
Version
8.2
Revision date
2025-01-20
Product name
Primidone
CAS No.
125-33-7
REACH No
A
Emergency telephone
+(47)-22591300, +(47)-21930678
Icons in SDS
Company Information
company name
Merck Life Science AS
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H351, H361d
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture Acute toxicity, (Category 4) H302: Harmful if swallowed. Carcinogenicity, (Category 2) H351: Suspected of causing cancer. Reproductive toxicity, (Category H361d: Suspected of damaging the unborn 2) child
Signal word
Warning Warning
Hazard statements
H302 Harmful if swallowed. H351 Suspected of causing cancer. H361d Suspected of damaging the unborn child. H351 Suspected of causing cancer. H361d Suspected of damaging the unborn child.
Precautionary statements
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P301 + P312 IF SWALLOWED: Call a POISON CENTER/ doctor if you feel unwell. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Supplemental label elements
none Reduced Labeling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Acute toxicity, (Category 4) H302: Harmful if swallowed. Carcinogenicity, (Category 2) H351: Suspected of causing cancer. Reproductive toxicity, (Category H361d: Suspected of damaging the unborn 2) child.
